In an earlier piece in The Wire, I laid out the driving forces and compulsions behind the coming together of major countries of the Global South and their attempt to forge different structures and ...

Some might say it looks like a finger. Others might see a worm. Scientists in the field often liken it to an antenna. The technical name is primary cilium. This slender, microscopic appendage juts out ...

Amlitelimab, dosed every four weeks or every 12 weeks, demonstrated statistically significant and clinically meaningful efficacy in skin clearance and disease severity compared to placebo at Week 24, ...

Positive results from the global COAST 1 phase 3 study (clinical study identifier: NCT06130566) showed that amlitelimab, a fully human non-T cell depleting monoclonal antibody that targets OX40-ligand ...

Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Amlitelimab, dosed every four weeks or every 12 weeks, ...

The Government has announced it is cracking down on the number of students in the UK who go on to claim asylum once their visas come to an end. Here the PA news agency looks at the key numbers and ...

A TOP Putin crony has warned the Kremlin might seize the "valuables of the British Crown" if the UK supports Ukraine with money from frozen Russian assets. Ex-Russian President Dmitry Medvedev accused ...

Despite years of engagement in a global chip war, China remains a vital operation base for several Asian-grown champions. But even from afar, Washington still holds key levers of power. The latest ...

Lululemon appears undervalued on traditional metrics, but weak revenue growth and rising costs undermine its risk-reward ...

Regeneron has reported a phase 3 win in generalized myasthenia gravis (gMG), positioning the pharma to file for FDA approval of its siRNA candidate in the increasingly competitive neuromuscular ...